Experimental study demonstrates visible-light-driven manganese-catalyzed C–H alkylation in complex heteroarenes and pharmaceuticals, highlighting an efficient radical chain pathway.
A visible‐light‐driven Minisci protocol that employs an inexpensive earth‐abundant metal catalyst, decacarbonyldimanganese Mn2(CO)10, to generate alkyl radicals from alkyl iodides has been developed. This Minisci protocol is compatible with a wide array of sensitive functional groups, including oxetanes, sugar moieties, azetidines, tert‐butyl carbamates (Boc‐group), cyclobutanes, and spirocycles. The robustness of this protocol is demonstrated on the late‐stage functionalization of complex nitrogen‐containing drugs. Photophysical and DFT studies indicate a light‐initiated chain reaction mechanism propagated by .Mn(CO)5. The rate‐limiting step is the iodine abstraction from an alkyl iodide by .Mn(CO)5.
No takes yet. Share an insight, caveat, or question.
Nuhant et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: